- Home
- KRMD vs TVGN Comparison
KRMD vs TVGN Comparison
Compare KRMD & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- TVGN
- Stock Information
- Founded
- KRMD 1980
- TVGN 2020
- Country
- KRMD United States
- TVGN United States
- Employees
- KRMD N/A
- TVGN N/A
- Industry
- KRMD Medical/Dental Instruments
- TVGN Blank Checks
- Sector
- KRMD Health Care
- TVGN Finance
- Exchange
- KRMD Nasdaq
- TVGN Nasdaq
- Market Cap
- KRMD 182.0M
- TVGN 174.4M
- IPO Year
- KRMD N/A
- TVGN N/A
- Fundamental
- Price
- KRMD $4.09
- TVGN $1.28
- Analyst Decision
- KRMD Strong Buy
- TVGN
- Analyst Count
- KRMD 5
- TVGN 0
- Target Price
- KRMD $4.50
- TVGN N/A
- AVG Volume (30 Days)
- KRMD 108.2K
- TVGN 1.6M
- Earning Date
- KRMD 03-12-2025
- TVGN 02-20-2025
- Dividend Yield
- KRMD N/A
- TVGN N/A
- EPS Growth
- KRMD N/A
- TVGN N/A
- EPS
- KRMD N/A
- TVGN N/A
- Revenue
- KRMD $31,993,796.00
- TVGN N/A
- Revenue This Year
- KRMD $17.79
- TVGN N/A
- Revenue Next Year
- KRMD $15.73
- TVGN N/A
- P/E Ratio
- KRMD N/A
- TVGN N/A
- Revenue Growth
- KRMD 11.57
- TVGN N/A
- 52 Week Low
- KRMD $1.98
- TVGN $0.26
- 52 Week High
- KRMD $4.60
- TVGN $21.09
- Technical
- Relative Strength Index (RSI)
- KRMD 58.06
- TVGN 52.84
- Support Level
- KRMD $3.81
- TVGN $1.20
- Resistance Level
- KRMD $4.19
- TVGN $1.57
- Average True Range (ATR)
- KRMD 0.20
- TVGN 0.15
- MACD
- KRMD -0.01
- TVGN 0.02
- Stochastic Oscillator
- KRMD 61.91
- TVGN 50.09
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.